JP2004532266A5 - - Google Patents

Download PDF

Info

Publication number
JP2004532266A5
JP2004532266A5 JP2003500073A JP2003500073A JP2004532266A5 JP 2004532266 A5 JP2004532266 A5 JP 2004532266A5 JP 2003500073 A JP2003500073 A JP 2003500073A JP 2003500073 A JP2003500073 A JP 2003500073A JP 2004532266 A5 JP2004532266 A5 JP 2004532266A5
Authority
JP
Japan
Prior art keywords
methyl
compound according
ylcarbonyl
thiazol
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003500073A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004532266A (ja
Filing date
Publication date
Priority claimed from GBGB0113233.1A external-priority patent/GB0113233D0/en
Application filed filed Critical
Publication of JP2004532266A publication Critical patent/JP2004532266A/ja
Publication of JP2004532266A5 publication Critical patent/JP2004532266A5/ja
Pending legal-status Critical Current

Links

JP2003500073A 2001-05-31 2002-05-29 心血管系疾患の治療に有用なチアゾールまたはオキサゾール誘導体 Pending JP2004532266A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0113233.1A GB0113233D0 (en) 2001-05-31 2001-05-31 Chemical compounds
PCT/EP2002/005885 WO2002096894A1 (en) 2001-05-31 2002-05-29 Thiazole or oxazole derivatives which are useful in the treatment of cardiovascular and related diseases

Publications (2)

Publication Number Publication Date
JP2004532266A JP2004532266A (ja) 2004-10-21
JP2004532266A5 true JP2004532266A5 (enExample) 2005-12-22

Family

ID=9915638

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003500073A Pending JP2004532266A (ja) 2001-05-31 2002-05-29 心血管系疾患の治療に有用なチアゾールまたはオキサゾール誘導体

Country Status (21)

Country Link
US (1) US6867225B2 (enExample)
EP (1) EP1392665B1 (enExample)
JP (1) JP2004532266A (enExample)
KR (1) KR20040007633A (enExample)
CN (1) CN1529698A (enExample)
AT (1) ATE377007T1 (enExample)
AU (1) AU2002312954B2 (enExample)
BR (1) BR0210077A (enExample)
CA (1) CA2448103A1 (enExample)
CO (1) CO5540299A2 (enExample)
CZ (1) CZ20033250A3 (enExample)
DE (1) DE60223245T2 (enExample)
ES (1) ES2295352T3 (enExample)
GB (1) GB0113233D0 (enExample)
HU (1) HUP0400056A2 (enExample)
IL (1) IL158818A0 (enExample)
MX (1) MXPA03010584A (enExample)
NO (1) NO20035316L (enExample)
PL (1) PL367215A1 (enExample)
WO (1) WO2002096894A1 (enExample)
ZA (1) ZA200308864B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105551B2 (en) * 2000-12-20 2006-09-12 Smithkline Beecham Corporation Thiazole derivatives for treating PPAR related disorders
GB0113231D0 (en) * 2001-05-31 2001-07-25 Glaxo Group Ltd Chemical compounds
GB0113232D0 (en) * 2001-05-31 2001-07-25 Glaxo Group Ltd Chemical process
EP1581525A2 (en) * 2002-08-09 2005-10-05 AstraZeneca AB Compounds having an activity at metabotropic glutamate receptors
US7553867B2 (en) 2002-09-06 2009-06-30 Takeda Pharmaceutical Company Limited Furan or thiophene derivative and medicinal use thereof
GB0314370D0 (en) * 2003-06-19 2003-07-23 Glaxo Group Ltd Chemical compounds
US20050203151A1 (en) * 2003-12-19 2005-09-15 Kalypsys, Inc. Novel compounds, compositions and uses thereof for treatment of metabolic disorders and related conditions
FR2866339B1 (fr) * 2004-02-18 2006-05-05 Pf Medicament Derives de 1,2,4-triazines, leur preparation et leur application en therapeutique humaine
DE102004051277A1 (de) * 2004-10-21 2006-04-27 Merck Patent Gmbh Heterocyclische Carbonylverbindungen
FR2882359A1 (fr) * 2005-02-24 2006-08-25 Negma Lerads Soc Par Actions S Derives activateurs de ppar, procede de preparation et application en therapeutique
FR2882750B1 (fr) * 2005-03-03 2007-05-11 Pierre Fabre Medicament Sa Derives de 1,2,4-triazines, leur preparation et leur application en therapeutique humaine
JP5225076B2 (ja) * 2006-04-27 2013-07-03 田辺三菱製薬株式会社 チアゾール環を含むカルボン酸誘導体の医薬用途
FR2901792A1 (fr) * 2006-06-06 2007-12-07 Negma Lerads Soc Par Actions S DERIVES ACTIVATEURS DE PPARs, PROCEDE DE PREPARATION ET APPLICATION EN THERAPEUTIQUE
WO2008035359A2 (en) * 2006-06-12 2008-03-27 Cadila Healthcare Limited Oximinophenoxyalkanoic acid and phenylalkanoic acid derivatives
BRPI0715160A2 (pt) 2006-08-08 2013-06-11 Sanofi Aventis imidazolidina-2,4-dionas substituÍdas por arilamimoaril-alquil-, processo para preparÁ-las, medicamentos compeendendo estes compostos, e seu uso
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE102007054497B3 (de) 2007-11-13 2009-07-23 Sanofi-Aventis Deutschland Gmbh Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung
US8470841B2 (en) 2008-07-09 2013-06-25 Sanofi Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
AU2009323367B2 (en) 2008-12-01 2013-05-23 Mitsubishi Tanabe Pharma Corporation Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereof
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
ES2443016T3 (es) 2009-08-26 2014-02-17 Sanofi Nuevos hidratos cristalinos de fluoroglicósidos heteroaromáticos, productos farmacéuticos que comprenden estos compuestos, y su empleo
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2582709B1 (de) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
WO2012120052A1 (de) 2011-03-08 2012-09-13 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
US8710050B2 (en) 2011-03-08 2014-04-29 Sanofi Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683705B1 (de) 2011-03-08 2015-04-22 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683704B1 (de) 2011-03-08 2014-12-17 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859051A (en) * 1996-02-02 1999-01-12 Merck & Co., Inc. Antidiabetic agents
US6207422B1 (en) * 1998-04-17 2001-03-27 The Metrohealth System Protein that enhances expression of potassium channels on cell surfaces and nucleic acids that encode the same
AU6501499A (en) * 1998-09-29 2000-04-17 Johns Hopkins University, The Inducible genetic suppression of cellular excitability
PE20011010A1 (es) * 1999-12-02 2001-10-18 Glaxo Group Ltd Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
EP1345916A1 (en) * 2000-12-20 2003-09-24 Glaxo Group Limited Substituted oxazoles and thiazoles as hppar alpha agonists

Similar Documents

Publication Publication Date Title
JP2004532266A5 (enExample)
JP2004517100A5 (enExample)
JP2005508905A5 (enExample)
JP2005529965A5 (enExample)
JP2004502756A5 (enExample)
JP2004534035A5 (enExample)
JP2011137006A5 (enExample)
JP2011511075A5 (enExample)
JP2009537524A5 (enExample)
NO20053211L (no) Forbindelser for behandling av metabolske forstyrrelser.
JP2003502369A5 (enExample)
JP2010523476A5 (enExample)
JP2004530656A5 (enExample)
CA2500964A1 (en) Cyclohexyl sulphone derivatives as gamma-secretase inhibitors
JP2005537248A5 (enExample)
JP2013532726A5 (enExample)
JP2002513793A5 (enExample)
JP2018135343A5 (enExample)
NO20064297L (no) Aminoalkoholforbindelse
JP2016531126A5 (enExample)
CA2626477A1 (en) Dicarboxylic acid derivatives and their use
JP2005526696A5 (enExample)
JP2011516511A5 (enExample)
JP2006509015A5 (enExample)
JP2004532267A5 (enExample)